With Sputnik V set for launch after its phase-three trial is completed, another Russian Covid-19 vaccine, EpiVacCorona, will be made available to the public next month. It is hoped that mass inoculation can begin in the New Year.
Developed by Siberia’s Vector Center, results from testing are ready to be presented, and an international publication is being sought to publish them, according to the head of the research body’s zoonotic infections and influenza department.
Continue reading https://on.rt.com/aw01